Latest news
CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 09:11:40 GMTCVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 07:34:48 GMTCVS Health Stock Slips 5% Despite Beating Quarterly Estimates and Raising Annual Guidance - TIKR.comTIKR.com · Thu, 06 Aug 2026 16:21:08 GMTUBS raises CVS Health stock price target to $126 on margin recovery - Investing.com South AfricaInvesting.com South Africa · Thu, 06 Aug 2026 13:43:35 GMTCVS Health posts strong Q2, raises full‑year 2026 guidance - Drug Store NewsDrug Store News · Thu, 06 Aug 2026 12:04:46 GMTCVS Health Q2 2026 slides: earnings surge, shares fall on outlook - Investing.com South AfricaInvesting.com South Africa · Thu, 06 Aug 2026 10:08:43 GMTCVS Health Raised Its Outlook, but the Stock Still Fell - Barron'sBarron's · Wed, 05 Aug 2026 20:41:00 GMTCVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 19:04:01 GMT